Haleon plc (NYSE:HLN) Receives $10.95 Average Price Target from Brokerages

Shares of Haleon plc (NYSE:HLN) have been given an average rating of “Buy” by the six analysts that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $10.95.

A number of research analysts recently weighed in on HLN shares. Morgan Stanley lifted their target price on shares of Haleon from $9.90 to $10.95 and gave the company an “overweight” rating in a research note on Friday, September 20th. The Goldman Sachs Group downgraded Haleon from a “buy” rating to a “neutral” rating in a research report on Tuesday, August 6th. Berenberg Bank began coverage on Haleon in a research note on Tuesday, August 6th. They issued a “buy” rating for the company. Finally, UBS Group raised Haleon to a “strong-buy” rating in a research note on Tuesday, October 1st.

Institutional Investors Weigh In On Haleon

Several large investors have recently made changes to their positions in HLN. Fortitude Family Office LLC purchased a new stake in shares of Haleon during the 3rd quarter valued at about $28,000. Toronto Dominion Bank raised its position in Haleon by 3,470.0% during the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock valued at $38,000 after purchasing an additional 3,470 shares during the period. Cultivar Capital Inc. bought a new stake in shares of Haleon in the 2nd quarter valued at approximately $40,000. Hexagon Capital Partners LLC boosted its holdings in shares of Haleon by 66.6% in the 2nd quarter. Hexagon Capital Partners LLC now owns 6,695 shares of the company’s stock worth $55,000 after purchasing an additional 2,677 shares during the period. Finally, Prospera Private Wealth LLC bought a new position in shares of Haleon during the 3rd quarter valued at approximately $57,000. 6.67% of the stock is owned by institutional investors.

Haleon Trading Up 1.0 %

Shares of Haleon stock opened at $9.65 on Friday. Haleon has a 1-year low of $7.89 and a 1-year high of $10.80. The company’s fifty day simple moving average is $10.01 and its 200-day simple moving average is $9.39. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The stock has a market capitalization of $43.68 billion, a PE ratio of 28.38, a P/E/G ratio of 2.88 and a beta of 0.30.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.